| Dr Candice Lovelace, DO | |
|
5400 W Hillsdale Ave, Visalia, CA 93291-8222 | |
| (559) 738-7599 | |
| (559) 739-0278 |
| Full Name | Dr Candice Lovelace |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 14 Years |
| Location | 5400 W Hillsdale Ave, Visalia, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215248307 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 4130 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaweah Delta Medical Center | Visalia, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adventist Health Physicians Network | 3274580972 | 499 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today Damian Marron, CEO, TxCell will be presenting at the 13th Annual BIO Investor Forum, October 7-8, 2014 at the Palace Hotel in San Francisco, California, US.
An innovative drug with a new mechanism of action that may be effective against a range of cancers will enter the first phase of clinical trials, it was announced today (Monday) at Cancer Research UK's Senior Researchers Meeting.
A Phase III, individually randomized trial has found conditional cash transfers for school attendance did not reduce the risk of HIV among high-school aged women in South Africa, investigators from the HIV Prevention Trials Network (HPTN) reported today at the 8th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada.
Bill Clinton is suggesting that mandatory testing for HIV/AIDS be used in countries with high infection rates and the means to provide lifesaving drugs.
Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported its financial results for the fourth quarter of 2012.
› Verified 8 days ago
| Entity Name | Adventist Health Physicians Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063718583 PECOS PAC ID: 3274580972 Enrollment ID: O20050407000633 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today Damian Marron, CEO, TxCell will be presenting at the 13th Annual BIO Investor Forum, October 7-8, 2014 at the Palace Hotel in San Francisco, California, US.
An innovative drug with a new mechanism of action that may be effective against a range of cancers will enter the first phase of clinical trials, it was announced today (Monday) at Cancer Research UK's Senior Researchers Meeting.
A Phase III, individually randomized trial has found conditional cash transfers for school attendance did not reduce the risk of HIV among high-school aged women in South Africa, investigators from the HIV Prevention Trials Network (HPTN) reported today at the 8th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada.
Bill Clinton is suggesting that mandatory testing for HIV/AIDS be used in countries with high infection rates and the means to provide lifesaving drugs.
Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported its financial results for the fourth quarter of 2012.
› Verified 8 days ago
| Entity Name | Kaweah Delta Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619353042 PECOS PAC ID: 4082923818 Enrollment ID: O20151019001526 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today Damian Marron, CEO, TxCell will be presenting at the 13th Annual BIO Investor Forum, October 7-8, 2014 at the Palace Hotel in San Francisco, California, US.
An innovative drug with a new mechanism of action that may be effective against a range of cancers will enter the first phase of clinical trials, it was announced today (Monday) at Cancer Research UK's Senior Researchers Meeting.
A Phase III, individually randomized trial has found conditional cash transfers for school attendance did not reduce the risk of HIV among high-school aged women in South Africa, investigators from the HIV Prevention Trials Network (HPTN) reported today at the 8th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada.
Bill Clinton is suggesting that mandatory testing for HIV/AIDS be used in countries with high infection rates and the means to provide lifesaving drugs.
Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported its financial results for the fourth quarter of 2012.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Candice Lovelace, DO 5400 W Hillsdale Ave, Visalia, CA 93291-8222 Ph: (559) 738-7599 | Dr Candice Lovelace, DO 5400 W Hillsdale Ave, Visalia, CA 93291-8222 Ph: (559) 738-7599 |
News Archive
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today Damian Marron, CEO, TxCell will be presenting at the 13th Annual BIO Investor Forum, October 7-8, 2014 at the Palace Hotel in San Francisco, California, US.
An innovative drug with a new mechanism of action that may be effective against a range of cancers will enter the first phase of clinical trials, it was announced today (Monday) at Cancer Research UK's Senior Researchers Meeting.
A Phase III, individually randomized trial has found conditional cash transfers for school attendance did not reduce the risk of HIV among high-school aged women in South Africa, investigators from the HIV Prevention Trials Network (HPTN) reported today at the 8th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada.
Bill Clinton is suggesting that mandatory testing for HIV/AIDS be used in countries with high infection rates and the means to provide lifesaving drugs.
Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported its financial results for the fourth quarter of 2012.
› Verified 8 days ago
Engracia Ferrer Flores, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5720 W Prospect Dr, Visalia, CA 93291 Phone: 661-721-2345 Fax: 661-721-6276 | |
Amit P Kamboj, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5400 W Hillsdale Ave, Visalia, CA 93291 Phone: 559-738-7532 | |
Rajinderpal S Chahal, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3335 S Fairway, Key Medical Associates, Visalia, CA 93277 Phone: 559-735-3881 | |
Dr. David J Heaney, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 515 W Acequia Ave Ste A, Visalia, CA 93291 Phone: 559-733-9707 Fax: 559-733-7009 | |
Dr. David M Hess, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-2314 | |
Asma Tariq, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-6999 | |
Jaime Foronda Dela Cerna, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Willow Plaza, Ste 210, Visalia, CA 93291 Phone: 559-625-5556 Fax: 559-625-5578 |